Skip to main content

Table 6 Meetings between Core Members and Rapid Review Group during the RAG development

From: Methodology and experiences of rapid advice guideline development for children with COVID-19: responding to the COVID-19 outbreak quickly and efficiently

Number of meetings Meeting Date Duration (h) Participants (number of attendances) Main Contents of the Meeting The form of the meeting
1st Feb-1 (14:30–17:15) 2.75 CM (4), MRRG (22) 1) Selection of the members of expert group
2) Discussion and optimization of initial clinical questions
3) Pre-preparation for the first round of clinical questions (preparation of materials, identification of leaders)
Teleconference – QQ
2nd Feb-6 (10:30–11:30) 1.0 CM (4), MRRG (20) 1) Feedback from the first round of clinical questions and expert opinion are discussed
2) Preparation of research materials for the second round of clinical questions
Teleconference – QQ
3rd Feb-7 (16:30–17:30) 1.0 CM (4), MRRG (8) 1) Discussion of late arrangements
2) Identification of final key clinical questions
Teleconference – QQ
4th Feb-11 (8:30–9:00) 0.5 CM (2), MRRG (24) 1) Discussion of the process of conducting rapid review
2) Identification of search strategies for each clinical question
Teleconference – QQ
5th Feb-15 (15:00–18:00) 3.0 CM (4), MRRG (22) 1) Discussion of preliminary evidence search results for each clinical question
2) Discussion of preliminary evidence summary
3) Adjustments to the search strategy for several clinical questions (supplementing other indirect evidence)
Teleconference – QQ
6th Feb-17 (19:00–22:30) 3.5 CM (5), MRRG (24) 1) Discussion of the results of the updated evidence summary
2) Discussion of the results of the adjusted evidence search for clinical questions
3) Drafted recommendations based on evidence summary
Teleconference – QQ
7th Feb-18 (20:10–22:55) 2.75 CM (5) 1) Modified the evidence summary expression and elaboration for each clinical question
2) Revision of the content of the recommendation
Teleconference – WeChat
8th Feb-19 (17:00–18:00) 1.0 CM (6), MRRG (10) 1) Modified the evidence summary expression and elaboration for each clinical question
2) Revision of the content of the recommendation
Teleconference – QQ
9th Feb-20 (14:00–18:45) 4.75 CM (5), MRRG (24) 1) Modified the evidence summary expression and elaboration for each clinical question
2) Revision of the content of the recommendation
3) Preparation of questionnaire materials for the first round of Delphi survey
Teleconference – QQ
10th Feb-21 (11:00–11:30) 0.5 CM (5) 1) Revision of the wording of the recommendation and evidence summary
2) Revision of the first round of Delphi questionnaire materials
Teleconference – WeChat
11th Feb-26 (19:00–22:45) 3.75 CM (5), MRRG (23) 1) Discussed the comments from the first round of Delphi survey one by one and revised the content of the recommendations
2) Responded to expert comments and produced feedback report
3) Preparation of questionnaire materials for the second round of Delphi survey
Teleconference – QQ
12th Feb-29 (9:00–12:00) 3.0 CM (5), MRRG (23) 1) Improved the content of the evidence summary and rationale section
2) Standardizing the format and wording of written content
Teleconference – QQ
13th Feb-29 (14:00–16:00) 2.0 CM (5), MRRG (23) 1) Improved the content of the evidence summary and rationale section
2) Standardizing the format and wording of written content
Teleconference – QQ
14th Mar-2 (18:00–19:00) 1.0 CM (6) 1) Discussed the comments from the second round of Delphi one by one and revised the content of the recommendations
2) Responded to expert comments and produced feedback report
3) Discussion of late arrangements (drafting the full guideline)
Teleconference – QQ
15th Mar-2 (20:00–21:30) 1.5 CM (5) 1) Revision of the content of the recommendations for each clinical question Teleconference –WeChat
16th Mar-3 (21:00–22:15) 1.25 CM (5) 1) Revision of the content of the recommendations for each clinical question Teleconference –WeChat
17th Mar-4 (18:00–20:15) 2.25 CM (5) 1) Revision of the guidelines based on expert comments
2) Drafting of the full text of the RAG
Teleconference – QQ
18th Mar-5 (19:00–20:00) 3.0 CM (5), MRRG (10) 1) Revision of the guidelines based on expert comments Teleconference – QQ
19th Mar-6 (17:00–20:00) 5.0 CM (6) 1) Identification of journals for submission
2) Identification of external reviewers
3) Revision of the guidelines based on expert comments
Teleconference – QQ
20th Mar-7 (13:20–15:20) 2.0 CM (3), MRRG (10) 1) Discussed 11 rapid reviews (full text) Teleconference – QQ
21st Mar-7 (19:15–21:45) 2.5 CM (5) 1) Revision of the guidelines based on external reviewers’ comments Teleconference – WeChat
Total NA 48 347 NA NA
Average NA 2.29 ± 1.30 16.5 ± 10.0 NA NA
  1. CM Core members. The core members include the Chair (Liu E), the Co-Chair (Smyth RL), the Chief Methodologist (Chen Y), the Expert Representative of the Guideline Development Group (Luo Z) and the Leaders of Rapid Review Group (Li W, Zhou Q, Ren L), MRRG Members of Rapid Review Group, QQ QQ is an instant messaging software service and web portal developed by the Chinese tech giant Tencent. QQ offers services that provide online social games, music, shopping, microblogging, movies, and group and voice chat software. WeChat WeChat is a Chinese multi-purpose messaging, social media and mobile payment app developed by Tencent, NA Not Applicable